SCHRODER INVESTMENT MANAGEMENT GROUP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$3,897,466
-2.1%
1,672,7320.0%0.01%0.0%
Q2 2023$3,981,102
+29.3%
1,672,7320.0%0.01%
+20.0%
Q1 2023$3,077,827
-3.2%
1,672,7320.0%0.01%0.0%
Q4 2022$3,178,191
-11.2%
1,672,7320.0%0.01%
-16.7%
Q3 2022$3,580,000
-24.4%
1,672,7320.0%0.01%
-14.3%
Q2 2022$4,734,000
-33.1%
1,672,7320.0%0.01%
-22.2%
Q1 2022$7,076,000
-18.5%
1,672,7320.0%0.01%
-18.2%
Q4 2021$8,681,000
-20.8%
1,672,7320.0%0.01%
-35.3%
Q3 2021$10,956,000
-1.4%
1,672,7320.0%0.02%
+21.4%
Q2 2021$11,107,000
+15.9%
1,672,7320.0%0.01%
+16.7%
Q1 2021$9,585,000
-68.0%
1,672,732
-50.0%
0.01%
-42.9%
Q4 2020$29,908,000
+72.3%
3,345,464
+113.7%
0.02%
-25.0%
Q3 2020$17,363,000
-39.3%
1,565,650
-12.3%
0.03%
-46.2%
Q2 2020$28,627,000
+115.2%
1,785,854
-14.8%
0.05%
+85.7%
Q1 2020$13,304,000
-51.9%
2,095,1270.0%0.03%
-37.8%
Q4 2019$27,656,0002,095,1270.04%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders